CRYOPORT INC (CYRX)

Commit To Buy CryoPort At $10, Earn 11% Annualized Using Options

CYRX Crosses Below Key Moving Average Level

Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for cell & gene therapies, today announced financial...

Noteworthy Tuesday Option Activity: DVA, X, CYRX

Noteworthy Wednesday Option Activity: CYRX, ABR, ACAD

Notable Wednesday Option Activity: CYRX, HLF, EYPT

Notable Tuesday Option Activity: RILY, CYRX, JBLU

Commit To Purchase CryoPort At $10, Earn 18% Annualized Using Options

CryoPort Breaks Above 200-Day Moving Average - Bullish for CYRX

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

/PRNewswire/ -- Cryoport Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

Cryoport Reports Third Quarter 2023 Financial Results

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the life...

Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

Noteworthy Friday Option Activity: SAVA, CYRX, CVLG

Oversold Conditions For CryoPort (CYRX)

Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023

/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

Commit To Purchase CryoPort At $10, Earn 21.4% Annualized Using Options

Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

Noteworthy Tuesday Option Activity: WING, CYRX, TRN

Cryoport to establish first U.K. logistics center (NASDAQ:CYRX)

Cryoport partners with Cell and Gene Therapy Catapult to build a global supply chain logistics center in the UK, expanding its presence in the region. Read more here.

Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

/PRNewswire/ -- Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and...

Relative Strength Alert For CryoPort

Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

The Law Offices of Frank R. Cruz Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Cryoport, Inc. (CYRX) on Behalf of Investors

Morgan Stanley starts Cryoport at equal weight, cites attractive fundamentals (CYRX)

Morgan Stanley has initiated coverage of Cryoport (CYRX) with an equal weight rating, citing the company's attractive long-term fundamentals and valuation. Read more here.

CryoPort GAAP EPS of -$0.42 misses by $0.17, revenue of $57.02M beats by $0.09M (NASDAQ:CYRX)

CryoPort press release (CYRX): Q2 GAAP EPS of -$0.42 misses by $0.17.Revenue of $57.02M (-11.2% Y/Y) beats by $0.09M.Cryoport's revenue for the full year 2023 is expected to be in...

Cryoport Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative products and services to the fast-growing...

Cryoport, Inc. (NASDAQ:CYRX) Investor Notice: Investigation over Possible Violations of Securities Laws

San Diego, CA -- (SBWIRE) -- 08/09/2023 -- Cryoport, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.